Regulatory Affairs Services Provider in Iraq
Entering the Iraqi healthcare market requires a clear understanding of local regulatory expectations, documentation requirements, registration procedures, and compliance obligations. For pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare innovators, navigating the regulatory environment can be complex without experienced local expertise.
DDReg provides comprehensive Regulatory Affairs Services in Iraq to help global companies successfully plan, prepare, submit, and maintain their healthcare products in compliance with Iraqi regulatory requirements. Our team helps organizations overcome regulatory challenges by combining global regulatory knowledge with a practical understanding of Iraq’s healthcare framework.
What Is the Pharmaceutical Regulatory Framework in Iraq?
Iraq has a structured regulatory system for medicines and healthcare products managed primarily under the supervision of the Ministry of Health (MOH) Iraq. The regulatory framework involves multiple departments responsible for product evaluation, registration, quality assessment, import controls, inspections, and post-market monitoring.
The Directorate of Technical Affairs within the Ministry of Health plays a central role in pharmaceutical regulation, including medicine approvals, marketing authorization, regulatory inspections, import and manufacturing licensing, quality control, and pharmacovigilance activities.
The State Company for Marketing Drugs and Medical Appliances (KIMADIA) is also an important organization within Iraq’s pharmaceutical supply ecosystem, particularly for medicine procurement, import-related activities, and distribution support for public healthcare requirements. For companies planning to introduce pharmaceutical products in Iraq, understanding these regulatory pathways is essential to avoid delays and ensure successful market entry.
How Does the Regulatory Authority Framework Work in Iraq?
The Iraqi regulatory framework involves coordination between different healthcare authorities and departments responsible for ensuring the safety, quality, and effectiveness of medical products.
Key Organizations Involved in Pharmaceutical Regulation and Supply in Iraq:
Ministry of Health (MOH) Iraq
The Ministry of Health is the primary governmental authority responsible for healthcare regulation, including pharmaceutical product oversight.
Its responsibilities include:
- Approval and registration of medicines
- Healthcare product quality evaluation
- Regulatory inspections
- Import and manufacturing approvals
- Monitoring product safety and compliance
Directorate of Technical Affairs
The Directorate of Technical Affairs is one of the key regulatory divisions responsible for pharmaceutical regulatory services in Iraq.
The Registration Department within the Directorate of Technical Affairs manages pharmaceutical product registration activities, including evaluation of registration submissions and regulatory documentation review.
Major functions include:
- Pharmaceutical product registration
- Evaluation of regulatory submissions
- Marketing authorization activities
- Quality and safety assessment
- Regulatory compliance monitoring
- Pharmacovigilance oversight
The Directorate manages regulatory processes related to medicines, vaccines, biological products, medical devices, diagnostics, herbal products, and other healthcare categories.
KIMADIA Drug Registration Services in Iraq and Pharmaceutical Supply Framework
KIMADIA plays an important role in Iraq’s pharmaceutical supply ecosystem, particularly in medicine procurement, import-related activities, and distribution requirements for public healthcare programs.
KIMADIA (State Company for Marketing Drugs and Medical Appliances) works under Iraq’s healthcare supply structure and manages activities related to medicine importation, procurement, storage, and distribution. Companies entering the Iraqi market need to understand how regulatory approval, product registration, supply authorization, and procurement processes interact.
Pharmaceutical Registration Pathway in Iraq
The pharmaceutical registration process in Iraq requires companies to submit complete technical and administrative documentation demonstrating product quality, safety, manufacturing standards, and therapeutic value. Although requirements may vary depending on product category, the general registration pathway includes the following stages:
1. Regulatory Strategy and Product Assessment
The first step in successfully registering a pharmaceutical product in Iraq is developing a clear regulatory strategy based on the product category, intended market, and applicable regulatory requirements. DDReg helps companies assess product eligibility for registration, identify the appropriate regulatory pathway, understand local representation requirements, and determine the documentation needed for submission. Our experts also evaluate supporting certificates, technical data, and regulatory requirements in advance to minimize delays and ensure a smooth registration process.
2. Preparation of Regulatory Dossier
A complete and well-structured regulatory dossier submission is essential for successful product registration in Iraq. DDReg supports companies in preparing and reviewing comprehensive submission packages, including administrative documents, manufacturing information, quality documentation, product specifications, stability data, clinical information where applicable, and supporting regulatory certificates. Our regulatory specialists ensure that documentation is organized, accurate, and aligned with Iraqi regulatory expectations before submission to the relevant authorities.
3. Regulatory Submission and Review
Once the regulatory dossier is prepared, the eCTD submission undergoes evaluation by the concerned regulatory authorities in Iraq. DDReg provides support throughout the review process by ensuring that submitted information adequately addresses key evaluation areas, including product quality, manufacturing compliance, safety profile, scientific justification, and supporting technical documentation. Our team assists with regulatory communication and helps manage responses to authority queries to maintain submission progress.
4. Approval and Marketing Authorization
After successful completion of the regulatory review process and fulfilment of all applicable requirements, companies can proceed toward obtaining marketing authorization for their products in Iraq. DDReg supports clients throughout the approval stage by helping manage regulatory documentation, approval-related requirements, and final compliance steps required for commercial distribution.
5. Post-Approval Regulatory Maintenance
Regulatory responsibilities continue even after a product receives approval. DDReg provides ongoing regulatory support to help companies maintain compliance throughout the product lifecycle in Iraq. Our services include management of variation submissions, renewal activities, regulatory updates, safety reporting requirements, and lifecycle management strategies to ensure continued product compliance and market sustainability.
How DDReg Supports Companies in Iraq?
Expanding into Iraq requires more than document submission. Companies need a regulatory partner who understands timelines, documentation expectations, and local regulatory practices.
DDReg supports clients through below regulatory services in Iraq:
-
Regulatory Strategy Development
We evaluate your product profile and develop an appropriate regulatory approach to improve registration efficiency.
-
Complete Dossier Management
Our team reviews, prepares, and manages regulatory documentation to ensure submission readiness.
-
Local Regulatory Understanding
We help global companies understand Iraq-specific regulatory expectations and compliance requirements.
-
Authority Interaction Support
DDReg assists with regulatory communication, clarification requests, and submission follow-up.
-
Lifecycle Regulatory Management
We continue supporting products after approval through variations, renewals, and regulatory updates.
-
Regulatory Consulting Iraq
DDReg provides pharma regulatory consulting in Iraq to help pharmaceutical, biotechnology, medical device, and healthcare companies understand local regulatory requirements, develop effective registration strategies, manage submissions, and maintain compliance throughout the product lifecycle.
Why Choose DDReg for Regulatory Affairs Services Partner in Iraq?
Choosing the right regulatory partner is essential for successful pharmaceutical market entry and long-term compliance in Iraq. DDReg combines global regulatory expertise, country-specific knowledge, and strategic regulatory support to help pharmaceutical, biotechnology, medical device, and healthcare companies navigate complex regulatory requirements with confidence.
Our capabilities include:
- 17+ Years of Global Regulatory Experience
- Comprehensive Regulatory Support Across the Product Lifecycle
- Expertise in Country-Specific Regulatory Requirements
- Experienced Regulatory Professionals
- Strategic Regulatory Planning and Risk Management
- Strong Regulatory Documentation Capabilities
- Dedicated Support for Regulatory Communication
- Commitment to Quality, Compliance, and Long-Term Partnership
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Iraq portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
